cyclohexanol has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbassi, R; Baell, J; Day, BW; Frye, S; Hoque, M; Munoz, L; Nguyen, N; Recasens, A; Stashko, MA; Wai Wong, S; Wang, X; Zhang, D | 1 |
| Dixit, D; Ghosh, S; Koul, N; Sen, E; Sharma, V | 1 |
2 other study(ies) available for cyclohexanol and Astrocytoma, Grade IV
| Article | Year |
|---|---|
MerTK activity is not necessary for the proliferation of glioblastoma stem cells.
Topics: Animals; c-Mer Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Cyclohexanols; Dose-Response Relationship, Drug; Glioblastoma; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrimidines; Xenograft Model Antitumor Assays | 2021 |
Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells.
Topics: Acrolein; Apoptosis; Blotting, Western; Brain Neoplasms; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclohexanols; Glioblastoma; Humans; Proto-Oncogene Proteins c-akt; Signal Transduction; Telomerase; TOR Serine-Threonine Kinases | 2010 |